Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b/2a, Double-blind, Placebo-controlled, Three Arm, Randomized Study Evaluating a Single Intravenous Push Followed by a Continuous Infusion of Certepetide Over 4 Hours When Added to Standard of Care (SoC) Versus Two Intravenous Pushes of Certepetide When Added to SoC, Versus SoC Alone in Subjects With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (FORTIFIDE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06592664
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:43.550395+00:00
Published At
2025-06-06T00:00:00+00:00
Record Updated At
2025-06-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreas Cancer", "Pancreatic Carcinoma", "Pancreas Adenocarcinoma", "Pancreatic Ductal Adenocarcinoma", "Unresectable Pancreatic Cancer", "Metastatic Pancreatic Cancer", "PDAC", "PDAC - Pancreatic Ductal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-06"
protocolSection.identificationModule.nctId
"NCT06592664"
protocolSection.identificationModule.officialTitle
"A Phase 1b/2a, Double-blind, Placebo-controlled, Three Arm, Randomized Study Evaluating a Single Intravenous Push Followed by a Continuous Infusion of Certepetide Over 4 Hours When Added to Standard of Care (SoC) Versus Two Intravenous Pushes of Certepetide When Added to SoC, Versus SoC Alone in Subjects With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (FORTIFIDE)"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pancreas Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
  • Pancreas Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • PDAC (protocolSection.conditionsModule.conditions)
  • PDAC - Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.